Supernus Pharmaceuticals, Inc. recalls Trokendi XR
- Recalling company
- Supernus Pharmaceuticals, Inc.
- Product
- Trokendi XR, (topiramate) extended-release capsules, 50 mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391 USA, Manufactured for: Supernus Pharmaceuticals, Inc., Rockville, MD 20850 USA, NDC 17772-102-30.
- Reason
- Failed dissolution specifications.
- Classification
- Class III – not likely to cause adverse health consequences
- Recall date
- Aug 31, 2026
- Reported
- Sep 9, 2026
- Distribution
- US Nationwide.
- Status
- Ongoing
- Quantity
- 11304 bottles
- Lot / codes
- Lot# 2145283, Exp Date: 31-Mar-2030.
- Company location
- Rockville, MD
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0833-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0833-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.